Stephanie Carson
Psychiatric/Mental Health · Evansville, INNPI 1437342532
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 582 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $4,386 and has fallen 86.2% since, to $604 in 2025. Among psychiatric/mental health clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 582 payments — averaging $16.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$887
- Sunovion Pharmaceuticals Inc.$839
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$794
- Axsome Therapeutics, Inc.$642
- Otsuka America Pharmaceutical, Inc.$576
- plus $5K from 26 others
What the payments were for
- Food & beverage$9,37899%
- Education$731%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 65 | $1,164 |
| Johnson & Johnson | 56 | $887 |
| Sunovion Pharmaceuticals Inc. | 109 | $839 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 35 | $794 |
| Axsome Therapeutics, Inc. | 19 | $642 |
| Otsuka America Pharmaceutical, Inc. | 22 | $576 |
| Corium, LLC | 34 | $565 |
| Supernus Pharmaceuticals, Inc. | 38 | $448 |
| Vanda Pharmaceuticals Inc. | 21 | $428 |
| Lundbeck LLC | 30 | $334 |
| Bausch Health US, LLC | 24 | $321 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $310 |
| Teva Pharmaceuticals USA, Inc. | 16 | $290 |
| Ironshore Pharmaceuticals Inc. | 18 | $289 |
| Tris Pharma Inc | 15 | $251 |
| Alkermes, Inc. | 11 | $238 |
| Neurocrine Biosciences, Inc. | 9 | $232 |
| Jazz Pharmaceuticals Inc. | 5 | $163 |
| Harmony Biosciences LLC | 6 | $138 |
| Indivior Inc. | 7 | $113 |
| Avanir Pharmaceuticals, Inc. | 3 | $91 |
| E.r. Squibb & Sons, L.L.C. | 2 | $85 |
| Neos Therapeutics, LP | 3 | $64 |
| Alfasigma USA, Inc. | 3 | $46 |
| Merck | 2 | $25 |
| OWP Pharmaceuticals, Inc. | 1 | $23 |
| Abbott | 1 | $21 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Pfizer | 1 | $14 |
| Almatica Pharma LLC | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,451 in reported general payments places this provider in the 95th percentile of 729 psychiatric/mental health providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olanzapine | 13 | $188 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Evansville
- John WathenEvansville$19K
- Melinda HaltermanEvansville$10K
- Brooke KempfTerre Haute$1.1M
- Gerald LewisMerrillville$336K
- Lauren LutzColumbus$320K
- Sonya RuedlingerIndianapolis$134K
- Trina GreenwaldMarion$107K
- Paul DuncanJeffersonville$46K
- Morgan StamperConnersville$42K
- Jennifer JimenezUnion Mills$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.